Previous Article | Next Article 
Infection and Immunity, June 2001, p. 4086-4093, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.4086-4093.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Nitric Oxide Is Protective in Listeric Meningoencephalitis
of Rats
K. A.
Remer,1
T. W.
Jungi,1,*
R.
Fatzer,2
M. G.
Täuber,3 and
S. L.
Leib3
Institutes of Veterinary
Virology,1 of Animal
Neurology,2 and of Infectious
Diseases,3 University of Berne, Berne,
Switzerland
Received 18 December 2000/Returned for modification 19 February
2001/Accepted 14 March 2001
 |
ABSTRACT |
The bacterium Listeria monocytogenes causes
meningoencephalitis in humans. In rodents, listeriosis is associated
with granulomatous lesions in the liver and the spleen, but not with
meningoencephalitis. Here, infant rats were infected intracisternally
to generate experimental listeric meningoencephalitis. Dose-dependent
effects of intracisternal inoculation with L. monocytogenes
on survival and activity were noted; 104 L. monocytogenes organisms induced a self-limiting brain
infection. Bacteria invaded the basal meninges, chorioid plexus and
ependyme, spread to subependymal tissue and hippocampus, and
disappeared by day 7. This was paralleled by recruitment and subsequent
disappearance of macrophages expressing inducible nitric oxide synthase
(iNOS) and nitrotyrosine accumulation, an indication of nitric oxide (NO·) production. Treatment with the spin-trapping agent
-phenyl-tert-butyl nitrone (PBN) dramatically increased
mortality and led to bacterial numbers in the brain 2 orders of
magnitude higher than in control animals. Treatment with the selective
iNOS inhibitor
L-N6-(1-iminoethyl)-lysine (L-NIL)
increased mortality to a similar extent and led to 1 order of magnitude
higher bacterial counts in the brain, compared with controls. The
numbers of bacteria that spread to the spleen and liver did not
significantly differ among L-NIL-treated, PBN-treated, and control
animals. Thus, the infant rat brain is able to mobilize powerful
antilisterial mechanisms, and both reactive oxygen and NO· contribute
to Listeria growth control.
 |
INTRODUCTION |
Listeria monocytogenes, a
gram-positive facultative intracellular rod, is the fourth most
frequent cause of community-acquired bacterial meningitis overall, and
the second most common pathogen in patients over 60 years of age and in
children younger than 1 month (46). Gastrointestinal
symptoms, bacteremia with liver and spleen involvement, and central
nervous system (CNS) infections are the most common clinical
presentations in patients (2, 44). The CNS disease often
includes an encephalitic component, with early mental status
alterations, cranial nerve deficits, and the occurrence of seizures.
Formation of abscesses in the brain stem leads to the clinical picture
of listeric rhombencephalitis. Serious cases can also result in
abortion in pregnant women (25, 27) (Centers for Disease
Control and Prevention, Atlanta, Ga. Media relations: facts about
listeriosis, http://www.cdc.gov/od/oc/media/fact/lister.htm). Despite antibiotic therapy, the mortality rate in infants and immunocompromised adults is as high as 30% (48). In
domestic animals, local outbreaks of listeriosis due to intake of
contaminated food are seen (19, 22, 42). Ruminants are of
particular interest in this regard because the bacterium can enter the
food chain via the milk or meat of apparently uninfected animals and present a hazard for humans (20, 21). L. monocytogenes has been extensively used as an experimental rodent
model to study cell-mediated immunity (15, 32, 39). In
these animals, L. monocytogenes causes bacteremia with
inflammation of liver and spleen without CNS involvement.
Nitric oxide (NO·) is a pleiotropic mediator playing an important
part in antimicrobial host defense against intracellular pathogens
(8, 33). Macrophages (M
) synthesize NO· by induction
of inducible nitric oxide synthase (iNOS) which converts
L-arginine and oxygen into L-citrulline and
NO·. A broad variety of intracellular pathogens are inhibited in their growth by NO· and its congeners. Although firmly established
for laboratory rodents, the ability of M
to synthesize
NO· exhibits a considerable interspecies variation, as has been
shown, e.g., for ruminant and human M
(12, 29, 45, 49),
and the role of NO· in human host defense against intracellular
pathogens is controversial. Furthermore, the role of NO· in
antilisterial activity is controversial (4, 6, 9, 18, 41,
43). Although the cited studies are of interest, it would be
desirable to have information as to whether NO· has a role in
antilisterial activity and/or damage in the CNS. To establish an
infection with L. monocytogenes in the brain, an
intracisternal infection model was developed in infant rats. In this
model, the host-pathogen relationship can be manipulated by varying the
numbers of bacteria used for inoculation. The model presented here was
a subacute self-limiting model of infection, allowing to study
mechanisms of innate host defense in the brain. Using this route of
infection, the role of NO· and other oxidants on the animals'
survival and the bacterial numbers in the brain were assessed. The
current study suggests that the brains of infant rats have powerful
antilisterial mechanisms and that iNOS-derived NO· is one among
several antilisterial mediators in the brain.
 |
MATERIALS AND METHODS |
Infecting organisms.
Bacteria used in the present study
belonged to a strain of L. monocytogenes (serotype 4b)
originally isolated from the cerebrospinal fluid (CSF) of a patient
with meningitis (34). Bacteria were grown on blood agar
plates. For infection, one bacterial colony was cultured overnight in
brain heart infusion, diluted in fresh medium, grown at 37°C for
3 h to logarithmic phase, pelleted, and resuspended in normal
saline to the desired density. The accuracy of the inoculum dose was
confirmed by quantitative bacteriology for each experiment.
Infection model.
An established model of bacterial
meningitis in infant rats (31) was modified. The animal
studies were approved by the Animal Care and Experimentation Committee
of the Canton of Bern, Switzerland, and followed National Institutes of
Health, Bethesda, Md., guidelines for the performance of animal
experiments. For all experiments, 11-day-old Sprague-Dawley rats with
their dam were purchased from RCC Biotechnology and Animal Breeding
(Füllingsdorf, Switzerland). The animals weighed 26 ± 4 g (mean ± standard deviation) at the onset of the
experiments and remained with their mother through the whole course of
the experiment.
Infant rats were infected by direct intracisternal injection of 10-µl
suspension of various doses of L. monocytogenes in saline ranging from 106 to 103 CFU by using a 32-gauge
needle. After infection, rats were returned to their mother. Body
weight and severity of the clinical symptoms were measured daily.
Clinical severity was scored according to an activity scale graded from
5 to 0. A score of 5 indicated that the animals showed normal activity,
4 indicated minimal disease (ability to turn to an upright position
within 5 s), 3 indicated moderate disease (unable to turn upright
within 5 s), 2 indicated severe disease (lethargic, no
ambulation), 1 indicated coma, and 0 indicated death. Animals which
developed a score of 2 or lower or became terminally ill (cyanotic,
exhibiting difficulty breathing or having seizures) were euthanatized
for ethical reasons, using intraperitoneal injections of pentobarbital
(200 mg/kg of body weight). These animals were henceforth scored as 0. The progress of the disease was such that this did not significantly
distort the results.
Inhibitor studies.
Two different inhibitors were used as
tools to delineate the role of NO· in the antilisteric mechanisms of
the CNS. First, the selective iNOS inhibitor
L-N6-(1-iminoethyl)-lysine · 2HCl (L-NIL; ALEXIS Biochemicals, San Diego, Calif.) was used. Animals
were injected subcutaneously with 5 mg of L-NIL per kg of body weight
in 0.3 ml of sterile saline 3 h before infection and then once a
day through the whole course of the experiment. Second, the
spin-trapping agent
-phenyl-tert-butyl nitrone (PBN)
(Calbiochem, Merck Eurolab, Darmstadt, Germany) was used. PBN acts by
scavenging of oxygen- or nitrogen-derived radicals or suppression of
their production (23, 36). PBN, which shows high
concentrations in the cerebrospinal fluid due to its lipophilicity
(10) was also administered subcutaneously 3 h before
infection and then twice daily at a concentration of 150 mg/kg of body
weight in saline. Animals of the control groups received 0.3 ml of
sterile saline alone at the same time.
Quantitative bacteriology.
Immediately after being
sacrificed, animals were perfused with phosphate-buffered saline (PBS)
via the left cardiac ventricle. The spleens, cerebellums, and parts of
the left liver lobes were removed aseptically, weighed, and homogenized
in a 10-fold amount (wt/vol) of sterile saline. Bacterial counts were
determined by plating 10-fold serial dilutions on blood agar plates
after 24 h of culture at 37°C. A minimum of one colony count
represented 1,000 CFU per g of organ tissue. For sterile cultures,
after 24 h at 37°C the value of the detection limit (1,000 CFU)
was used for statistical analysis.
Immunohistochemistry.
Animals were perfused either with 4%
paraformaldehyde in PBS or with PBS alone if quantitative bacteriology
was performed at the same time. The brains were harvested and immersion
fixed in 4% paraformaldehyde in PBS. Slices of coronar cross sections of the thalamus region were embedded in paraffin, cut in 4-µm sections on a microtome, and mounted on positively charged glass slides.
Slides were deparaffinized shortly prior to immunohistochemical
staining. Endogenous peroxidase was inactivated by treatment with
H2O2 (1% in PBS for 15 min at room
temperature). For L. monocytogenes and nitrotyrosine (NT)
staining, antigens first had to be retrieved by treatment with trypsin
(2 mg of trypsin 250 [Difco Laboratories, Detroit, Mich.] per ml in
50 mM Tris buffer, pH 7.5) for 15 min at 37°C on a shaker. Fc
receptors were blocked by treatment with human immunoglobulin G (IgG)
(10 mg of Globuman Berna [Swiss Serum and Vaccine Institute, Berne,
Switzerland] per ml of PBS). Slides were covered with the specific
antibodies diluted in dilution buffer (20 mM Tris, 0.25 M NaCl, 0.1%
Tween 20, pH 7.5) at the concentrations given below for 1 h at
37°C, followed by an appropriate second antibody diluted in dilution
buffer, and incubated for 45 min at 37°C. The Vectastain ABC Elite
kit for peroxidase reaction or the Vectastain ABC-AP kit for alkaline
phosphatase reaction, both from Vector (Geneva, Switzerland), or the
Histostain-Plus broad spectrum kit (AEC) from Zymed (San Francisco,
Calif.) was used as a detection system. With the Vectastain kits,
either diaminobenzidine (DAB tablets; Sigma, St. Louis, Mo.) or fast
red (1 mg of fast red [Chroma Gesellschaft, Schmid GmbH, Köngen,
Germany] per ml plus 0.5 mg of Naphthol SX-MX per ml in 100 mM
Tris-HCl, pH 8) was used as a substrate. With the Histostain-Plus kit,
AEC served as a substrate and was included in the test kit. Slides were
then embedded using Glycergel (DAKO, Glostrup, Denmark).
The primary antibodies used were as follows. For iNOS staining, a
polyclonal rabbit anti-iNOS antibody (catalog no. 573, Upstate Biotechnology Inc., Lake Placid, N.Y.) was used at a dilution of 1:200;
for L. monocytogenes staining, a polyclonal rabbit
anti-L. monocytogenes antibody (serotypes 1 and 4, Difco
Laboratories) at 1:200; and for detection of NT either a polyclonal
NT-specific antibody (Upstate Biotechnology Inc.) at 1:200 or a
monoclonal anti-NT antibody (kindly provided by M. Shigenaga,
University of California
Berkeley) at 1:25 was used. The properties of
the last antibody will be published in detail elsewhere (I. Girault et
al., unpublished data). A validation of the NT staining is described
elsewhere (H. Pfister et al., submitted for publication). Staining for
the rat pan-M
marker ED1 was performed with a monoclonal antibody
from Serotec (Oxford, United Kingdom) at 1:100. ED1 is expressed on
blood-derived M
and activated microglia. As activated microglia
cells and M
could not be differentiated in our model, the term M
was used to encompass both blood-derived M
and activated microglia cells.
For the secondary antibodies, either the biotinylated anti-rabbit IgG
(Jackson Immunoresearch Laboratories, West Grove, Pa.) specific for the
polyclonal antibodies or a biotinylated goat anti-mouse IgG (human and
rat serum absorbed, Kirkegaard & Perry Laboratories, Inc., Gaithesburg,
Md.) specific for the monoclonal antibodies was applied.
Evaluation of immunohistochemistry results.
In order to
objectively score the staining intensity, slides were randomized and
scored in a blinded fashion from 0 to 4. Individual scores for the
meninges and plexus and periventricular regions were calculated as
averages of three and four microscopic fields, respectively. A score of
0 indicated that there was no positive staining on the slide, 1 referred to an average of less than 2 positive cells, 2 indicated 2 to
20 positive cells, 3 indicated between 21 and 200 positive cells, and 4 indicated more than 200 positive cells. The scores were then averaged
for each individual animal.
Statistical analysis.
For determining statistical
significance, data from identical experimental groups run in several
experiments were compiled. Results were expressed as averages ± standard deviations unless otherwise indicated. Multiple group
comparisons were performed by nonparametric one-way analysis of
variance (Kruskal-Wallis test). For group comparisons, the Mann-Whitney
test was used. Survival curves were analyzed by the Kaplan-Meier test.
 |
RESULTS |
Dose response and time course of intracisternal inoculation with
L. monocytogenes.
Infant rats of 11 days of age were
inoculated with several doses of L. monocytogenes, ranging
from 103 to 106 CFU, by the intracisternal
route (Table 1). Rats were monitored over
time with regard to mortality and morbidity (Fig.
1). Infant rats inoculated with
106 CFU or more of L. monocytogenes showed
marked decreases in their activity scores and succumbed to the
infection within the first 3 days. Animals inoculated with
103 to 105 CFU showed transient decreases in
their activity scores around day 2 of infection. Mortality in the group
inoculated with 105 CFU was 60% and was much lower in the
groups inoculated with 103 and 104 CFU, with
animals succumbing to the infection only rarely. Additional observations suggested that animals which survived until day 5 recovered from the infection. As an appropriate dose, 104
CFU of L. monocytogenes was chosen for subsequent
experiments in which the course of the infection was followed for up to
1 week. Days 3, 5, and 7 were selected as time points to sacrifice the
animals for immunohistochemistry, while days 2, 4, and 7 were used to
sacrifice the animals for quantitative bacteriology, due to the high
mortality rate of inhibitor-treated animals after day 2 (see below).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Survival (A) and activity (B) profiles of rats
inoculated intracisternally with various doses of L. monocytogenes. Data were compiled from three experiments; each
dose group contained four or more animals. Symbols refer to doses of
L. monocytogenes as follows: closed squares, 103
CFU; open triangles, 104 CFU; open circles, 105
CFU; open diamonds, 106 CFU.
|
|
Kinetics of L. monocytogenes growth.
Immunohistochemical staining showed L. monocytogenes inside
phagocytic cells of M
-like appearance and free in the tissue. The
organisms were located in the basal meninges, the chorioid plexus, and
the ependyme. Bacteria were abundant at day 3 of infection. At day 5 the bacteria had spread further into the subependymal tissue and in the
hippocampus, causing fulminant local inflammation, but had already
started to disappear from the meninges (Fig.
2A and 3A to D). At day 7, few bacteria
were still present in the inflamed areas.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Growth kinetics of and tissue infiltration by L. monocytogenes in the brains of intracisternally infected rats.
Tissues were analyzed at various times after infection with
104 CFU of L. monocytogenes. (A) Scores taken in
a blind fashion in meninges (closed symbols) and in plexus and
periventricular regions (open symbols) were averaged for individual
animals as described in Materials and Methods. Each group consisted of
a minimum of five rats. The horizontal lines indicate the medians of
the groups (B) CFU of L. monocytogenes in spleen (hatched
dots), liver (open dots), and cerebellum (black dots) tissues. For
animals with no detectable bacteria, the threshold of detection was
entered. The detection threshold is indicated in the graph by the
dotted line.
|
|
L. monocytogenes injected intracisternally also spread to
other organs. Thus, bacteria were detected in the liver and spleen around day 2 but already had declined at day 4 and dropped to subdetectable levels at day 7 (Fig. 2B).
Pathological findings.
The inflammation was restricted to the
basal meninges, the chorioid plexus, the ependyme, and subependymal
tissue. At day 3, the animals showed moderate purulent meningitis, mild
purulent ependymitis with many mononuclear cells, plexus chorioiditis, and inflammation of the hippocampus with infiltration of
polymorphonuclear leukocytes and M
. At day 5, the inflammation had
spread to the subependymal tissue, where strong abscess formation,
especially around the third ventricle, could be observed. M
became
the dominant cell type in the inflamed areas of the hippocampus and
also in the subependyme as revealed by immunohistochemistry. At day 7, the number of inflammatory cells around the ventricles and in the
hippocampus had declined. Few inflammatory cells were left in the
meninges. As a remnant of the inflammation, dilatation of the lateral
ventricles and destruction of the hippocampus could be observed.
Expression of iNOS.
iNOS was expressed by cells in foci
of infection (Fig. 3A to E). The majority
of these iNOS-expressing cells were M
. Weak iNOS expression
could also be observed in a subset of polymorphonuclear leukocytes, as
indicated by nucleus morphology. At day 3, strong iNOS expression could
be observed in the basal meninges, the chorioid plexus, and the
hippocampus. While iNOS expression in the meninges already declined at
day 5, it further intensified in the subependymal tissue around the
third ventricle and the hippocampus, where it declined only at day 7 (Fig. 3D and 4A). The expression of iNOS was colocalized with bacteria in the tissue, and the presence of
bacteria could also be demonstrated directly inside M
expressing iNOS (Fig. 3C). At day 7, when bacteria had almost disappeared, iNOS
expression was limited to only a small number of M
in close proximity to bacteria.

View larger version (142K):
[in this window]
[in a new window]
|
FIG. 3.
Rat brain sections showing areas of inflammation due to
infection with L. monocytogenes around the third ventricle.
They were stained for bacteria (red, panels A to D), iNOS (brown,
panels A to E), or NT (brown, panel F). L indicates the lumen of the
ventricle. TD indicates tissue destruction due to massive inflammation.
Arrows point to intracellular bacteria. (A) Ependymal tissue at day 3. (B) Subependymal tissue at day 5. (C) Sequestration of bacteria at day
5. (D) Clearing of infection at day 7. (E) Overview of the third
ventricle at day 3 after infection showing staining for iNOS; insert,
iNOS-expressing M . (F) Section adjacent to E stained for NT, insert,
NT granules in M . Magnification, ×400 (A to D), ×100 (E and F),
and ×3,000 (inserts of E and F). The bars in E and F represent 1 mm.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Kinetics and tissue distribution of iNOS (A) and NT (B)
in the brains of intracisternally infected rats. Tissues were analyzed
at days 3, 5, and 7 postinfection with 104 CFU of L. monocytogenes. Scores were determined in meninges (filled
triangles) and in the plexus and periventricular regions (open
triangles) as described in Materials and Methods. The animals analyzed
here were the same as those used for Fig. 2. The horizontal lines
indicate the medians of the groups.
|
|
Expression of NT.
The expression of iNOS suggests, but does
not prove, the local synthesis of NO·. One of the footprints of
NO· in tissues is NT (5, 7, 16, 28). Therefore, the
appearance of NT in the tissue is a hallmark of NO· formation.
Immunohistochemical staining showed the onset of NT formation as early
as day 3. Significant amounts of NT were seen in the form of massive
granules of various sizes inside cells of M
type around day 5 (Fig.
3F and 4B). NT-containing cells were located in abscesses and inflamed
areas with infiltration of M
. They were in close contact with
iNOS-expressing cells, although the NT-containing cells themselves only
weakly expressed iNOS, if at all. Strongly iNOS-expressing cells
contained no or only single small NT granules. Toward the end of
iNOS-expression, at day 7, the presence of NT could no longer be demonstrated.
Effect of treatment with L-NIL and PBN.
The observation that
iNOS expression and NT accumulation precede the disappearance of
L. monocytogenes is consistent with a role of NO· in
antilisterial host defense in the brain. To substantiate this, infant
rats were treated with the competitive iNOS inhibitor L-NIL shortly
before being infected with L. monocytogenes. At the chosen doses, L-NIL had no adverse effect on the survival and activity of
healthy animals as determined in preliminary experiments (data not
shown). In contrast, animals inoculated with 104 CFU of
L. monocytogenes treated with L-NIL prior to infection died
between days 2 and 4, whereas infected control animals succumbed to the
infection only occasionally (Fig. 5).
This was confirmed in experiments in which amino guanidine was used as
an iNOS inhibitor (data not shown). Numbers of bacteria in the
cerebellums, livers, and spleens were determined. The iNOS inhibitor
L-NIL significantly increased the number of bacteria in the cerebellum;
the increases seen in the liver and spleen were not significant.
Immunohistochemistry of the thalamus region showed that L. monocytogenes scores in this part of the brain had increased
accordingly (Fig. 6).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 5.
Survival of rats infected with L. monocytogenes and treated with either PBN (open circles) or L-NIL
(open triangles) or left untreated (closed squares). The graph
incorporates several experiments. Each group represents at least 13 animals.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
L. monocytogenes growth in organs of animals
treated with a selective iNOS inhibitor, L-NIL. (A) L. monocytogenes score at day 2 as determined in L-NIL-treated (open
triangles) or mock-treated animals (closed triangles). (B) CFU in
spleen, liver, and cerebellum tissues at day 2 after treatment with
L-NIL (hatched dots) or mock treatment (open dots). The graph accounts
for 15 animals per group, infected at different days. The difference
between the control group and the L-NIL-treated group is significant
(P < 0.01) for the cerebellum. The dotted line
indicates the threshold of detection. Horizontal bars indicate the
medians in each panel.
|
|
When using the spin-trapping agent PBN, animals succumbed to the
infection between days 2 and 3 (Fig. 5). PBN significantly increased
the bacterial counts in the cerebellums, livers, and spleens of the
infected animals by about 2 orders of magnitude. Immunohistochemistry
of the thalamus region revealed that elevated L. monocytogenes scores appeared concomitantly with an increase of
the iNOS scores (Fig. 7 and data not
shown).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 7.
L. monocytogenes growth in organs of animals
treated with PBN. (A) L. monocytogenes scores at day 2 as
determined in PBN-treated (open triangles) or mock-treated animals
(closed triangles). (B) CFU in cerebellum, spleen, and liver tissues at
day 2 after treatment with PBN (hatched dots) or mock treatment (open
dots). The graph accounts for 13 animals per group, infected at
different days. The differences in the results of control and
PBN-treated tissues are significant (P < 0.001) for
all groups. The dotted line indicates the threshold of detection.
Horizontal bars represent medians of the groups in each panel.
|
|
 |
DISCUSSION |
An infection with L. monocytogenes causes
meningoencephalitis in humans but granulomatous lesions in the liver
and spleen in rodents. We have established an experimental model of
listeric meningoencephalitis using an intracisternal route of
infection. Infant rats infected intracisternally with a moderate dose
of L. monocytogenes developed a self-limiting
meningoencephalitis. Bacteria spread to other organs such as the liver
and the spleen, but powerful antilisterial mechanisms led to a complete
elimination of L. monocytogenes from the brain and other
organs. Dose-response studies showed that survival and behavioral
activity of the animals are dependent on the number of L. monocytogenes organisms used for inoculation. This model is
therefore suited to study host defense mechanisms against L. monocytogenes in the brain.
The L. monocytogenes-induced inflammation was mainly
restricted to the ventricles, chorioid plexus, and the neighboring
tissue, which demonstrates that L. monocytogenes has a
preference for the ependyme and subependymal tissue in the infant rat
model. This histopathological picture closely resembles the situation in human meningoencephalitis, which is due to a hematogenous spread of
L. monocytogenes to the brain.
Current infective encephalitis models are usually acute and fatal
within 3 days. This is also true for models of murine listeric meningoencephalitis (24). An intracisternal inoculation
has the advantage that the brain is minimally damaged by the injection, thereby causing minimal trauma and nonspecific inflammation. A listeriosis model using intracisternal infection of infant rats has
recently been published (34). Whereas that model used high bacterial numbers, in the present model lower numbers were used. This
allowed to address recovery, to monitor the infection kinetically, and
to study which host defense elements contribute to survival and recovery.
One candidate mediator contributing to rapid elimination of L. monocytogenes from the brain is, at least in the rat,
macrophage-derived NO· or its congeners. Several lines of evidence
support the notion that NO· synthesized by iNOS does contribute to
the growth control and/or elimination of the bacteria in the brain: (i)
we show by immunohistochemistry that iNOS is strongly expressed in foci
of L. monocytogenes infection but not in other sites of the
brain; (ii) staining for NT suggests that the enzyme iNOS is active;
(iii) abolishment of iNOS-mediated NO· synthesis by a selective iNOS
inhibitor significantly impairs survival and increases the number of
bacteria in the brain, as shown by quantitative bacteriology of the
cerebellum and by microscopic examination of the hypothalamus area.
Earlier rodent studies indicate that the role of NO· in
antilisterial activity is controversial (4, 6, 9, 18, 41,
43). In one study, NO· was shown to contribute to bacterial
elimination in rodent but not in human M
(6). The
latter were shown by many other groups not to contribute to
iNOS-mediated NO· synthesis to a large extent (12, 45,
49).
Examination of the sections showed a preferential expression of iNOS in
M
; neutrophils were only occasionally stained, and if so, only
weakly. This parallels our findings in ruminants, in which neutrophils
were negative for iNOS in listeric encephalitis (30). It
is noteworthy that others reported iNOS to be expressed by rat
neutrophils in other systems (35, 50).
When NO· was prevented from being synthesized, bacterial numbers
were moderately increased (12-fold, on the average). In contrast, when
both reactive oxygen and nitrogen species were downregulated with PBN
(23, 36), bacterial numbers were increased by 2 orders of
magnitude in all organs tested. A likely explanation for this discrepancy is that oxidants other than NO· also contribute to the
control of L. monocytogenes growth in the rat brain. This is
consistent with in vitro studies showing that both reactive oxygen and
nitrogen species contribute to antilisterial host defense
(41). Genetic deficiency of a constituent of the NAD(P)H-dependent oxidase has a moderate effect on resistance to a
listeria infection (13, 17), and deficiency in both the iNOS gene and the NAD(P)H-dependent oxidase gene renders the animals more susceptible to an L. monocytogenes infection than
deficiency in a single gene only (47). In addition to an
antilisterial effect of the single agents NO· and
O2
, a recent in vitro study suggested that
the combined effect can be explained by a mechanism mediated by
peroxynitrite, a direct reaction product of NO· and
O2
(37).
Tissue-associated NT may be regarded as a hallmark of local
NO· synthesis be it due to nitration by peroxynitrite or by the more recently described mechanism based on a reaction of nitrite and hypochlorous acid (16). In this study, it was manifested
in the form of granules which were seen mainly within macrophages. Specificity for NT was demonstrated (i) by disappearance of staining in
the presence of free NT, (ii) by lack of a color reaction upon pretreatment of the sections with dithionite, and (iii) by
obtaining parallel results with four distinct NT-specific antibodies
(H. Pfister et al., submitted for publication). Observations over time
showed that NT disappeared shortly after the disappearance of iNOS. The
exact nature of antibody-labeled nitrated proteins and the
characteristics of their removal remain to be investigated.
The temporally and spatially limited NT expression is consistent with
the view that either NO· or its congener peroxynitrite is generated
in the same area in which the bacteria are seen and in which iNOS is
being expressed. The observation that a given cell preferentially
expresses either iNOS or NT does not detract from this idea, since
there could be a temporal difference between iNOS expression and NT accumulation.
The present study suggests that in the rat brain, early resistance to
L. monocytogenes is mediated by mechanism(s) abolished by
PBN. Several reasons argue for the involvement of innate mechanisms. These include the kinetics of bacterial spread, followed by growth control, the paucity of lymphocytes observed in lesions (K. A. Remer, unpublished observation), and the observation that heat-killed L. monocytogenes combined with gamma interferon is one of
the strongest inducer of iNOS in cultured M
. Both neutrophils
(11) and gamma interferon-producing cells other than T
cells (1, 3, 14, 38, 40) have been reported to be
essential for controlling an L. monocytogenes infection in
the murine liver and spleen. Recovery from an infection at a later time
point may be less dependent on these mediators. Older studies show that both innate and acquired immune mechanisms contribute to antilisterial host defense. There is evidence that acquired resistance, which rests
on both activated CD4 and CD8 cells, is less dependent on NO· than
innate resistance (26, 43).
In conclusion, we developed a new model of infection with L. monocytogenes allowing experimental manipulation by varying the number of bacteria inoculated and by using specific inhibitors. We
provide evidence that reactive nitrogen intermediates produced before
an effective T-cell response could be established have a role in
antilisterial defense in the brain. Future studies have to evaluate
more precisely the role of nitric oxide versus other oxidants in
cerebral antilisterial defense mechanisms and the contribution to host
defense by cells other than macrophages.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Swiss National Science
Foundation (54041.98, 32-61654, and NRP 4038-52841) and the National
Institutes of Health (NS-35902).
The technical assistance of Hedi Pfister, Andrea Grunder, Carmen
Cardoso, and Oliver Schuetz is gratefully appreciated. We acknowledge
the critical reading of the manuscript by and the helpful discussions
with E. Peterhans, Institute of Veterinary Virology, and S. Christen,
Institute of Infectious Diseases, University of Berne.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Veterinary Virology, University of Berne, Laenggassstrasse 122, CH-3012 Berne, Switzerland. Phone: 41 31 6312502. Fax: 41 31 6312534. E-mail:
jungi{at}ivv.unibe.ch.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Andersson, A.,
W. J. Dai,
J. P. Di Santo, and F. Brombacher.
1998.
Early IFN-gamma production and innate immunity during Listeria monocytogenes infection in the absence of NK cells.
J. Immunol.
161:5600-5606[Abstract/Free Full Text].
|
| 2.
|
Armstrong, R. W., and P. C. Fung.
1993.
Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes; case report and review Clin.
Infect. Dis.
16:689-702.
|
| 3.
|
Bancroft, G. J.,
R. D. Schreiber, and E. R. Unanue.
1989.
T cell-independent macrophage activation in scid mice.
Curr. Top. Microbiol. Immunol.
152:235-242[Medline].
|
| 4.
|
Beckerman, K. P.,
H. W. Rogers,
J. A. Corbett,
R. D. Schreiber,
M. L. McDaniel, and E. R. Unanue.
1993.
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes.
J. Immunol.
150:888-895[Abstract].
|
| 5.
|
Beckman, J. S., and W. H. Koppenol.
1996.
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.
Am. J. Physiol.
271:C1424-C1437[Abstract/Free Full Text].
|
| 6.
|
Bermudez, L. E.
1993.
Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide.
Clin. Exp. Immunol.
91:277-281[Medline].
|
| 7.
|
Betz Corradin, S.,
J. Mauel,
P. Gallay,
D. Heumann,
R. J. Ulevitch, and P. S. Tobias.
1992.
Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein.
J. Leukoc. Biol.
52:363-368.
|
| 8.
|
Bogdan, C.,
M. Röllinghoff, and A. Diefenbach.
2000.
The role of nitric oxide in innate immunity.
Immunol. Rev.
173:17-26[CrossRef][Medline].
|
| 9.
|
Boockvar, K. S.,
D. L. Granger,
R. M. Poston,
M. Maybodi,
M. K. Washington,
J. B. Hibbs, Jr., and R. L. Kurlander.
1994.
Nitric oxide produced during murine listeriosis is protective.
Infect. Immun.
62:1089-1100[Abstract/Free Full Text].
|
| 10.
|
Chen, G.,
M. Griffin,
J. L. Poyer, and P. B. McCay.
1990.
HPLC procedure for the pharmacokinetic study of the spin-trapping agent, alpha-phenyl-N-tert-butyl nitrone (PBN).
Free Radic. Biol. Med.
9:93-98[Medline].
|
| 11.
|
Conlan, J. W., and R. J. North.
1994.
Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody.
J. Exp. Med.
179:259-268[Abstract/Free Full Text].
|
| 12.
|
Denis, M.
1994.
Human monocytes/macrophages: NO or no NO?
J. Leukoc. Biol.
55:682-684[Abstract].
|
| 13.
|
Dinauer, M. C.,
M. B. Deck, and E. R. Unanue.
1997.
Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes.
J. Immunol.
158:5581-5583[Abstract].
|
| 14.
|
Dunn, P. L., and R. J. North.
1991.
Early gamma interferon production by natural killer cells is important in defense against murine listeriosis.
Infect. Immun.
59:2892-2900[Abstract/Free Full Text].
|
| 15.
|
Edelson, B. T., and E. R. Unanue.
2000.
Immunity to listeria infection.
Curr. Opin. Immunol.
12:425-431[CrossRef][Medline].
|
| 16.
|
Eiserich, J. P.,
M. Hristova,
C. E. Cross,
A. D. Jones,
B. A. Freeman,
B. Halliwell, and A. van der Vliet.
1998.
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils.
Nature
391:393-397[CrossRef][Medline].
|
| 17.
|
Endres, R.,
A. Luz,
H. Schulze,
H. Neubauer,
A. Futterer,
S. M. Holland,
H. Wagner, and K. Pfeffer.
1997.
Listeriosis in p47 (phox / ) and TRp55 / mice protection despite absence of ROI and susceptibility despite presence of RNI.
Immunity
7:419-432[CrossRef][Medline].
|
| 18.
|
Fehr, T.,
G. Schoedon,
B. Odermatt,
T. Holtschke,
M. Schneemann,
M. F. Bachmann,
T. W. Mak,
I. Horak, and R. M. Zinkernagel.
1997.
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.
J. Exp. Med.
185:921-931[Abstract/Free Full Text].
|
| 19.
|
Fenlon, D. R.
1985.
Wild birds and silage as reservoirs of Listeria in the agricultural environment.
J. Appl. Bacteriol.
59:537-543[Medline].
|
| 20.
|
Fenlon, D. R.,
T. Stewart, and W. Donachie.
1995.
The incidence, numbers and types of Listeria monocytogenes isolated from farm bulk tank milks.
Lett. Appl. Microbiol.
20:57-60[Medline].
|
| 21.
|
Fenlon, D. R.,
J. Wilson, and W. Donachie.
1996.
The incidence and level of Listeria monocytogenes contamination of food sources at primary production and initial processing.
J. Appl. Bacteriol.
81:641-650[Medline].
|
| 22.
|
Fligger, J. M.,
J. W. Blum, and T. W. Jungi.
1999.
Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro.
Immunobiology
200:169-186[Medline].
|
| 23.
|
Floyd, R. A., and K. Hensley.
2000.
Nitrone inhibition of age-associated oxidative damage.
Ann. N. Y. Acad. Sci.
899:222-237[CrossRef][Medline].
|
| 24.
|
Frei, K.,
D. Nadal,
H. W. Pfister, and A. Fontana.
1993.
Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10.
J. Exp. Med.
178:1255-1261[Abstract/Free Full Text].
|
| 25.
|
Goulet, V., and P. Marchetti.
1996.
Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions.
Scand. J. Infect. Dis.
28:367-374[Medline].
|
| 26.
|
Harty, J. T., and D. White.
1999.
A knockout approach to understanding CD8+ cell effector mechanisms in adaptive immunity to Listeria monocytogenes.
Immunobiology
201:196-204[Medline].
|
| 27.
|
Hof, H.,
T. Nichterlein, and M. Kretschmar.
1997.
Management of listeriosis.
Clin. Microbiol. Rev.
10:345-357[Abstract].
|
| 28.
|
Ischiropoulos, H.,
L. Zhu,
J. Chen,
M. Tsai,
J. C. Martin,
C. D. Smith, and J. S. Beckman.
1992.
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.
Arch. Biochem. Biophys.
298:431-437[CrossRef][Medline].
|
| 29.
|
Jungi, T. W.,
H. Adler,
B. Adler,
M. Thöny,
M. Krampe, and E. Peterhans.
1996.
Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation.
Vet. Immunol. Immunopathol.
54:323-330[CrossRef][Medline].
|
| 30.
|
Jungi, T. W.,
H. Pfister,
H. Sager,
R. Fatzer,
M. Vandevelde, and A. Zurbriggen.
1997.
Comparison of inducible nitric oxide synthase expression in the brains of Listeria monocytogenes-infected cattle, sheep, and goats and in macrophages stimulated in vitro.
Infect. Immun.
65:5279-5288[Abstract].
|
| 31.
|
Leib, S. L.,
Y. S. Kim,
L. L. Chow,
R. A. Sheldon, and M. G. Täuber.
1996.
Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci.
J. Clin. Investig.
98:2632-2639[Medline].
|
| 32.
|
Mackaness, G. B.
1962.
Cellular resistance to infection.
J. Exp. Med.
116:381-406[Abstract].
|
| 33.
|
MacMicking, J.,
Q. W. Xie, and C. Nathan.
1997.
Nitric oxide and macrophage function.
Annu. Rev. Immunol.
15:323-350[CrossRef][Medline].
|
| 34.
|
Michelet, C.,
S. L. Leib,
D. Bentue-Ferrer, and M. G. Täuber.
1999.
Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes.
Antimicrob. Agents Chemother.
43:1651-1656[Abstract/Free Full Text].
|
| 35.
|
Miles, A. M.,
M. W. Owens,
S. Milligan,
G. G. Johnson,
J. Z. Fields,
T. S. Ing,
V. Kottapalli,
A. Keshavarzian, and M. B. Grisham.
1995.
Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes.
J. Leukoc. Biol.
58:616-622[Abstract].
|
| 36.
|
Miyajima, T., and Y. Kotake.
1995.
Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice.
Biochem. Biophys. Res. Commun.
215:114-121[CrossRef][Medline].
|
| 37.
|
Muller, M.,
R. Althaus,
D. Frohlich,
K. Frei, and H. P. Eugster.
1999.
Reduced antilisterial activity of TNF-deficient bone marrow-derived macrophages is due to impaired superoxide production.
Eur. J. Immunol.
29:3089-3097[CrossRef][Medline].
|
| 38.
|
Munder, M.,
M. Mallo,
K. Eichmann, and M. Modolell.
1998.
Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation.
J. Exp. Med.
187:2103-2108[Abstract/Free Full Text].
|
| 39.
|
North, R. J.,
P. L. Dunn, and J. W. Conlan.
1997.
Murine listeriosis as a model of antimicrobial defense.
Immunol. Rev.
158:27-36[CrossRef][Medline].
|
| 40.
|
Ohteki, T.,
T. Fukao,
K. Suzue,
C. Maki,
M. Ito,
M. Nakamura, and S. Koyasu.
1999.
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells.
J. Exp. Med.
189:1981-1986[Abstract/Free Full Text].
|
| 41.
|
Ohya, S.,
Y. Tanabe,
M. Makino,
T. Nomura,
H. Xiong,
M. Arakawa, and M. Mitsuyama.
1998.
The contributions of reactive oxygen intermediates and reactive nitrogen intermediates to listericidal mechanisms differ in macrophages activated pre- and postinfection.
Infect. Immun.
66:4043-4049[Abstract/Free Full Text].
|
| 42.
|
Rebhun, W. C., and A. deLahunta.
1982.
Diagnosis and treatment of bovine listeriosis.
J. Am. Vet. Med. Assoc.
180:395-398[Medline].
|
| 43.
|
Samsom, J. N.,
J. A. Langermans,
P. H. Groeneveld, and R. van Furth.
1996.
Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates.
Infect. Immun.
64:1197-1202[Abstract].
|
| 44.
|
Schlech, W. F. I.
2000.
Foodborne listeriosis.
Clin. Infect. Dis.
31:770-775[CrossRef][Medline].
|
| 45.
|
Schneemann, M.,
G. Schoedon,
S. Hofer,
N. Blau,
L. Guerrero, and A. Schaffner.
1993.
Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.
J. Infect. Dis.
167:1358-1363[Medline].
|
| 46.
|
Schuchat, A.,
K. Robinson,
J. D. Wenger,
L. H. Harrison,
M. Farley,
A. L. Reingold,
L. Lefkowitz, and B. A. Perkins.
1997.
Bacterial meningitis in the United States in 1995. Active surveillance team.
N. Engl. J. Med.
337:970-976[Abstract/Free Full Text].
|
| 47.
|
Shiloh, M. U.,
J. D. MacMicking,
S. Nicholson,
J. E. Brause,
S. Potter,
M. Marino,
F. Fang,
M. Dinauer, and C. Nathan.
1999.
Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase.
Immunity
10:29-38[CrossRef][Medline].
|
| 48.
|
Skogberg, K.,
J. Syrjanen,
M. Jahkola,
O. V. Renkonen,
J. Paavonen,
J. Ahonen,
S. Kontiainen,
P. Ruutu, and V. Valtonen.
1992.
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy.
Clin. Infect. Dis.
14:815-821[Medline].
|
| 49.
|
Weinberg, J. B.,
M. A. Misukonis,
P. J. Shami,
S. N. Mason,
D. L. Sauls,
W. A. Dittman,
E. R. Wood,
G. K. Smith,
B. McDonald, and K. E. Bachus.
1995.
Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.
Blood
86:1184-1195[Abstract/Free Full Text].
|
| 50.
|
Yui, Y.,
R. Hattori,
K. Kosuga,
H. Eizawa,
K. Hiki,
S. Ohkawa,
K. Ohnishi,
S. Terao, and C. Kawai.
1991.
Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils.
J. Biol. Chem.
266:3369-3371[Abstract/Free Full Text].
|
Infection and Immunity, June 2001, p. 4086-4093, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.4086-4093.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Deckert, M., Virna, S., Sakowicz-Burkiewicz, M., Lutjen, S., Soltek, S., Bluethmann, H., Schluter, D.
(2007). Interleukin-1 Receptor Type 1 Is Essential for Control of Cerebral but Not Systemic Listeriosis. Am. J. Pathol.
170: 990-1002
[Abstract]
[Full Text]
-
Schild, M., Gianinazzi, C., Gottstein, B., Muller, N.
(2007). PCR-Based Diagnosis of Naegleria sp. Infection in Formalin-Fixed and Paraffin-Embedded Brain Sections. J. Clin. Microbiol.
45: 564-567
[Abstract]
[Full Text]